Me
Metsera
New York NYFounded 202230 employees
Private CapbiotechPrivateMetabolic
Platform: Oral Obesity
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixafutibatinib | MET-3656 | Preclinical | 2 | SMN2 | IgANNB | ||
| Geliglumide | MET-1311 | Phase 1 | 2 | PI3Kα | BCCCF | ||
| Nidarelsin | MET-1497 | Phase 2/3 | 1 | BCL-2 | TTR AmyloidosisOvarian Ca | ||
| MET-3015 | MET-3015 | Preclinical | 1 | MET | MCL |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)